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We present the first case of abnormal neuroimaging in a case of infant botulism. The
clinical findings of the patient with constipation, bulbar weakness, and descending,
symmetric motor weakness are consistent with the classic findings of infant botulism.
Magnetic resonance imaging (MRI), however, revealed restricted diffusion in the brain and
enhancement of the cervical nerve roots. Traditionally, normal neuroimaging was used
to help differentiate infant botulism from other causes of weakness in infants. Abnormal
neuroimaging is seen in other causes of weakness in an infant including metabolic
disorders and hypoxic–ischemic injury, but these diagnoses did not fit the clinical findings
in this case. The explanation for the MRI abnormalities in the brain and cervical nerve roots
is unclear as botulinum toxin acts at presynaptic nerve terminals and does not cross the
blood–brain barrier. Possible explanations for the findings include inflammation from the
botulinum toxin at the synapse, alterations in sensory signaling and retrograde transport
of the botulinum toxin. The patient was treated with human botulism immune globulin and
had rapid recovery in weakness. A stool sample from the patient was positive for Type
A Clostridium botulinum toxin eventually confirming the diagnosis of infant botulism. The
findings in this case support use of human botulism immune globulin when the clinical
findings are consistent with infant botulism despite the presence of MRI abnormalities in
the brain and cervical nerve roots.
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INTRODUCTION
A 5-month-old male infant presented with progressive weakness. Two weeks prior to presentation,
the infant developed constipation that improved with stool softeners. He subsequently developed
difficulty feeding, ptosis, and weakness in his trunk and extremities. On presentation, the infant
was afebrile with age-appropriate vital signs. Cranial nerve exam was notable for bilateral ptosis
and a weak grimace. Motor exam was notable for diffuse appendicular and axial hypotonia with
significant head lag and a positive scarf sign. The infant was born at term with no significant
past medical history. His diet consisted of primarily breast milk with no exposure to honey
or well water. Social history was notable for residence in a farming community in Western
Nebraska. Results of his newborn screen were unavailable, but his parents were not aware of any
abnormalities.
Initial evaluation including complete blood count, complete metabolic panel, lactate, and uri-
nalysis was unremarkable. Metabolic screening labs, including serum amino acids, acylcarnitine
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FIGURE 1 | Trace diffusion-weighted image of the brain demonstrates
hyperintensity along the optic radiations [arrowheads in (A)], with
corresponding hypointensity on ADC map [arrowheads in (B)],
compatible with restricted diffusion. Restricted diffusion was also faintly
present in the corpus callosum splenium [arrow in (C)] and dorsal pons
[curved arrow in (D)].
profile, and urine organic acids, were normal. Cerebrospinal fluid
(CSF) had 0 white blood cells, 0 red blood cells, protein of
21mg/dL, and glucose of 65mg/dL. A nasopharyngeal sample
tested positive bymultiplex viral polymerase chain reaction (PCR)
for rhino/enterovirus. Enterovirus PCR testing of CSF, throat, and
rectal swabs was negative.
The infant was admitted to the Pediatric Intensive Care Unit
for respiratory monitoring and further evaluation. Magnetic res-
onance imaging (MRI) of the brain and spine was performed on
a 3-T Philips Ingenia magnet. Brain diffusion-weighted imaging
demonstrated restricted diffusion of the corpus callosum, sple-
nium, bilateral optic radiations, and dorsal pons (Figures 1A–D).
There was no abnormal brain parenchyma or cranial nerve
enhancement. Magnetic resonance spectroscopy over the optic
radiations was normal (not shown). MRI of the spine revealed
symmetric cervical nerve root enhancement without spinal cord
signal abnormality (Figures 2A,B). Electrophysiological studies
were not performed.
BACKGROUND
Infant botulism is a toxin-mediated infectious disorder that causes
constipation, bulbar weakness, and descending, symmetric motor
weakness (1). Over 3,000 cases of infant botulism have been
FIGURE 2 | Axial post-contrast T1-weighted image through the
cervical spine, ventral, and dorsal cervical nerve roots abnormally
enhance [thin arrows in (B), compare to non-contrast image at same
level in (A)].
reported since 1976. Most of these cases have been reported in
the US with 80–100 cases annually (2). The diagnosis of infant
botulism must be made clinically for timely administration of
botulism immune globulin (BabyBIG) and later confirmed by
a Clostridium botulinum mouse bioassay. Sensitivity of clinical
diagnosis of infant botulism has not been studied, but Arnon et al.
reported that 122 of 129 patients with clinical suspicion for infant
botulism treated with BabyBIG later had laboratory confirmation
of the disease (3). Treatment with BabyBIG decreases length and
cost of hospital stay aswell as severity of illness but ismost effective
when given early in the disease course. The findings in this case
including constipation, bulbar palsy, and descending, symmetric
motor weakness are consistent with symptoms in other cases of
infant botulism.
DISCUSSION
Given the history and exam consistent with infant botulism along
with CSF reassuring against infectious or autoimmune etiolo-
gies for the infant’s weakness, the infant was treated empir-
ically with BabyBIG on hospital day 2 despite the abnormal
neuroimaging. After treatment with BabyBIG, the infant had
rapid improvement in weakness and was discharged on hospital
day 5. A stool sample was obtained via enema prior to dis-
charge and sent for C. botulinum mouse bioassay at the Cen-
ters for Disease Control and Prevention that later confirmed the
presence of Type A C. botulinum toxin. On phone follow-up
6months after admission, the parents reported that the patient
continued to have constipation but no other residual neurolog-
ical problems. The parents declined follow-up imaging despite
being made aware of the abnormalities present on the initial
study.
This is the first reported case of infant botulism associated with
abnormal MRI findings in the brain and cervical nerve roots.
The findings may be incidental but support the use of BabyBIG
in infants with suspected infant botulism despite neuroimaging
abnormalities. Reviews of infant botulism do not discuss neu-
roimaging findings as part of the diagnosis and several recent case
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reports of infant botulism reported normal brainMRI findings (1,
4–7). Attenuated cortical thickening over the frontal and temporal
lobes has been described in one case report of infant botulism,
but this imaging was done by head computed tomography (CT)
during the recovery phase of the illness in a patient with per-
sistent neurological abnormalities (8). Normal neuroimaging has
traditionally been used to help differentiate infant botulism from
alternative causes of acute flaccid paralysis in the infant, including
demyelinating diseases,metabolic disorders, ischemia, spinal cord
compression, and neoplastic process.
Enterovirus infection causing flaccid paralysis was consid-
ered in this case given the nasal swab PCR positive for
rhino/enterovirus, but the history of constipation and descend-
ing weakness, the diffusion-weighted changes on brain MRI, the
lack of spinal cord signal abnormality, and the rapid improve-
ment after BabyBIG administration was not consistent with
the recently described association of enterovirus D68 and acute
flaccid myelitis (9, 10). Other causes of weakness in an infant
could cause neuroimaging abnormalities similar to those seen
in this case but were similarly inconsistent with the clinical
course.Metabolic disorders,mitochondrial disease, and leukodys-
trophies can cause central and peripheral nerve injury and
demonstrate symmetric patterns of central restricted diffusion.
These diseases, however, would not respond to BabyBIG and
would be expected to causes ongoing clinical symptoms. Addi-
tionally, the absent lactate peak on spectroscopy over the area
of restricted diffusion would be atypical in the acute imaging
of mitochondrial disease. Hypoxic–ischemic injuries can cause
white matter restricted diffusion, but this case lacked a history
suggestive of hypoxic injury and the pattern of imaging find-
ings, specifically the cervical nerve root enhancement, would be
atypical.
It is possible that the neuroimaging abnormalities found in this
case are not unique for cases of infant botulism but have not been
previously detected as imaging is infrequently acquired and ongo-
ing improvements in MRI techniques and technology may have
made the findings more obvious. The abnormal enhancement of
the cervical nerve roots correlated with the bulbar weakness seen
in the patient. The potential mechanism of nerve root enhance-
ment is puzzling since botulinum toxin acts at presynaptic nerve
terminals. One explanation is that the finding represents inflam-
mation of the nerve root caused by either the neurotoxin at the
synapse or by retrograde signaling. It is more difficult to explain
the brain diffusion-weighted findings, as botulinum toxin does
not cross the blood–brain barrier. Botulinum toxin specificity is
derived from its binding to specific gangliosides and other recep-
tors on the presynaptic nerve terminal (11). Once endocytosis
occurs, it is possible that retrograde transport could lead to direct
effects on the CNS, and studies have suggested that botulinum
toxin may inhibit neurotransmitters other than acetylcholine.
Other studies have shown that altered sensory input produced by
botulinum toxin can cause indirect changes in the central nervous
system (12). It is unclear if the brain diffusion-weighted findings
in this case could be a direct effect of the toxin through retrograde
transport, an indirect effect on peripheral and sensory nerves, or
incidental.
CONCLUDING REMARKS
We report the first known case of abnormal neuroimaging find-
ings in a case of infant botulism. Although unusual for this dis-
ease, abnormal MRI findings should not absolutely exclude this
diagnosis in the setting of other characteristic clinical findings.
The findings in this case support treatment of suspected infant
botulism with BabyBIG despite the unusual neuroimaging find-
ings of restricted diffusion in the brain and cervical nerve root
enhancement.
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